The lowered price target from $260 to $230 by BMO Capital analyst Michael Zaremski indicates a potential negative short-term impact on Willis Towers Watson's stock price. The Market Perform rating suggests that the stock is expected to perform in line with the market, but the reduced price target may cause investors to reevaluate their positions and potentially sell the stock, leading to a decrease in its price.